Registration is open for the 'Ludwig Conference on Alternative Nucleic Acid Conformations in Health and Disease' (28 Sept–2 Oct, Oxford), which aims to bring together researchers studying Z-DNA, Z-RNA, R-loops, triplexes and more! Secure your place now 👇 atozconference2026.my.canva.site

Already excited for next year's congress? Make sure to save the date in your calendars, and sign up for #EACR2027 updates! eepurl.com/dvcaQf

What a fantastic day at the Oxford Cancer Immuno-Oncology Network Symposium! A huge thank you to our speakers, poster presenters and delegates. 👏

A warm welcome to Sebastian Amigorena (Immunity and Cancer Unit, Institut Curie, Paris @institutcurie.bsky.social), who is joining us as the keynote speaker at today's OCION Symposium. 👏

It's your last chance to vote for your favourite poster at today's Oxford Cancer Immuno-Oncology Network Symposium! If you're in attendance today, be sure to cast your vote before the end of the break.🗳️

Kicking off this afternoon's talks: Members of Oxford Cancer's PPI Team, Catriona Gilmour-Hamilton and Julliet Lwiindi discuss 'Patient and Public Involvement in fundamental research', alongside DPhil Student, Alex Colton @oncology.ox.ac.uk.

Today at the OCION Symposium: Jie Yang @oxcio.bsky.social presents: "Aspirin enhances T cell immunity to cancer metastasis” & Om H. Gandhi, also @oxcio.bsky.social, covers: “Peptide and enzyme-level dissection of a TAP–cytosolic aminopeptidase axis of tumour immune escape”

Halfway through today's Oxford Cancer Immuno-Oncology Network Symposium! lf you're in attendance today, don't forget to check out the posters on display in the networking area. 👇

Oxford Cancer Immuno-Oncology Network (OCION) Director @timmunologist.bsky.social shares the network’s achievements to date at today’s Symposium. Since launching in 2023, OCION has awarded £199,367 in pump-prime funding to accelerate innovative cancer immuno-oncology research across Oxford. 👏

Great to be here at @oxfordmathematics.bsky.social for today's Oxford Cancer Immuno-Oncology Network Symposium! 🥼 Thanks to all our sponsors: @novogene-europe.bsky.social, Immunocore, Immudex, @britsocimm.bsky.social, Olink & Immunotherapy Advances!

Submit an abstract by July 13 for the San Antonio Breast Cancer Symposium (December 8-11), presented by UT Health San Antonio in collaboration with the AACR. Learn more: buff.ly/98T3KHj #SABCS26

🎉 Congratulations to the brilliant Kennedy Histology Team (Ida Parisi, Oyindamola Ajisegiri and Ugne Radziukaite) who have won the May 2026 Cancer Research UK Research is Beautiful competition! 🔬🧫 https://news.cancerresearchuk.org/2026/06/05/latest-winner-in-our-research-is-beautiful-competition-3/

Looking for funding to support your research? Our new internal research funding pages bring together opportunities from across @OxfordMedSci & @UniofOxford in one place making it easier! https://www.medsci.ox.ac.uk/research/internal-research-funding/internal-research-funding

Submit an abstract by July 13 for the AACR Conference on Pancreatic Cancer (Sept 25-28; San Diego), chaired by Andrew J. Aguirre, Florencia McAllister, Kenneth P. Olive, Eileen O’Reilly, Diane M. Simeone, and Colin D. Weekes. buff.ly/pSzoa0m #AACRpan26

We're delighted to share the appointment of Prof Adam Mead as Director of Oxford Cancer, joining Profs Mark Middleton and Tim Elliott in leading Oxford’s interdisciplinary cancer research community. 👏 @ouhospitals.bsky.social @medsci.ox.ac.uk @imm.ox.ac.uk www.cancer.ox.ac.uk/news/profess...

The Fellows of the AACR Academy Cancer Research Impact Grants are one-year, $75,000 awards that support early-career investigators nearing completion of postdoctoral or clinical research training. Apply by June 30. Learn more: buff.ly/GeLhnOj #AACRGrants

And we're off! 🎉 @sarahblagden.bsky.social kicks off today's #PPIE event, exploring the potential of treatments to prevent cancer with our fantastic public and patient contributors. ✨

A change of scene for today! @oxfordcancer.bsky.social has taken over the cinema for a day to talk about preventing cancer with vaccines with our brilliant public and patient contributors. Looking forward to an interesting day of discussions! #PPIE

Phase 1 of the INTERCEPT-Lynch trial, which is funded by Moderna and sponsored by the University of Oxford, has received authorisation from the Medicines and Healthcare products Regulatory Agency and is expected to begin recruiting participants this summer. 👏 www.cancer.ox.ac.uk/news/first-t...

New paper from lab: many congratulations to Rebecca, Alia and Lucy who led this work. And thanks to all collaborators and funders. @paediatrics.ox.ac.uk @imm.ox.ac.uk @oxfordcancer.bsky.social ashpublications.org/blood/articl...

A big thank you to everyone who joined us for yesterday's Oxford Pancreatic Cancer Research Networking Day! 👏 The day showcased the breadth of #PancreaticCancer research taking place across our community and highlighted the importance of collaboration in driving progress for patients.

Submit an abstract by July 13 for the San Antonio Breast Cancer Symposium (December 8-11), presented by UT Health San Antonio in collaboration with the AACR. Learn more: buff.ly/98T3KHj #SABCS26

Some great discussion & collaboration at today's Oxford Pancreatic Cancer Research Networking Day! 👏 Featuring a talk on Patient and Public Involvement (PPI) in research from our wonderful PPI Team! More on our website 👇 www.cancer.ox.ac.uk/support/PPI-... #PancreaticCancer #CancerResearch

Are you considering a future in clinical research? Join us for a 45-minute session highlighting clinical research fellowship opportunities in Oxford across a range of specialities.   🗓️ Tuesday 16 June ⏰ 6pm 📍 Online   Register now 👉 https://forms.office.com/e/ad1pNcRQN8

Last chance to apply for STEP1 of our new Oxford Cancer Immuno-Oncology Network Phoenix funding scheme! 💷up to £20,000 available 🥼For: Projects that will help define Oxford’s unique approach to Immuno-Oncology. 📆Deadline: 1st June 2026, at midnight. www.cancer.ox.ac.uk/ocion-fundin...

📢 Registration to attend the OCION symposium will be open until 12:00, Thursday 29 of May, but spaces are limited.

Yesterday (20th May) was #InternationalClinicalTrialsDay On this day in 1747, navy surgeon James Lind began the world’s first clinical trial: www.clinicaltrialsday.org/about To learn about the MILI trial and LFS, visit mili.octru.ox.ac.uk #TP53 #LFS @oncology.ox.ac.uk @oxfordcancer.bsky.social

Don't forget to secure your place at the 2026 OCION Symposium! 📢 If you're interested in presenting a flash talk or a poster, the deadline for abstract submissions has been extended until next Wednesday, 27 May 2026. Register below 👇 @oncology.ox.ac.uk @oxcio.bsky.social @medsci.ox.ac.uk

#WIMMinFocus 🧪 We have featured this beautiful image before, and now it is wonderful to see it recognised as Cancer Research UK’s April #ResearchIsBeautiful winner. Congrats to Natalie Jooss from the Psaila Lab! #SciComm #Microscopy @cancerresearchuk.org @rdm.ox.ac.uk @medsci.ox.ac.uk #AcademicSky

This Friday, we are carrying out the first CIO Fun Run™️, a non-competitive 5-10K for everyone in our department, with a social drinks and snacks get-together afterwards. We are raising money for #CancerResearchUK @cruk-mi.bsky.social 🏃‍♂️🏃🏾‍♀️🏃🏼‍♀️🏃🏻🏃🏽‍♂️ Donate here: fundraise.cancerresearchuk.org/page/cio-run...

Researchers, students, and industry representatives recently came together for 'Neutrophils in Cancer', an event exploring the growing potential of neutrophil biology in cancer therapy. Thanks to all our speakers and attendees! 👏👇 www.cancer.ox.ac.uk/news/neutrop...

It was wonderful to host the CRIS Cancer Foundation's science and communications teams last week for a day of presentations, discussions, and lab visits. It was fantastic opportunity to share research and strengthen collaborations! 🔬🥼

A fantastic day of discussion and collaboration at the Oxford Liver Cancer Centre of Excellence Symposium today. 🥼 Thank you to all our speakers and attendees for making it such a success! 👏

Today we’ve published a new report, ‘Turning evidence into impact’, to reflect on some of the achievements from the past decade we’re most proud of, including the recent passing into law of the Tobacco & Vapes Bill. Read the report in full: cruk.ink/3R5Wtn9.

It's our 2nd Annual Oxford Liver Cancer Centre of Excellence (OLivE) Symposium today! 🥳 We're looking forward to a day of talks on: 🔎Cancer detection 🤝Patient & public involvement & engagement 🧪Immunology & vaccines ⚗️Spatial biology Find out more about OLivE 👇 www.youtube.com/watch?v=F6El...

NEWS: World’s largest study of women’s health marks 30 years of pioneering research Celebrating 30 years of a major study on the links between hormone replacement therapy (HRT) and breast cancer risk. @oxpop.bsky.social 

Ludwig TEE is a 2-day interdisciplinary meeting in Oxford exploring the regulatory layers shaping gene expression, spanning transcription, epigenetics and epitranscriptomics. When: 7–8 Oct 📆 For: Oxford & Non-Oxford Attendees 🥼 Register ⬇️ www.oxforduniversitystores.co.uk/conferences-...

Researchers have developed a novel OXPHOS inhibitor designed to reduce tumour hypoxia, a major cause of radiotherapy resistance. By reducing oxygen consumption in tumour cells, the compound increases oxygen availability within tumours, alleviating hypoxia & potentially increasing radiosensitivity.

TRAINING: Communicating your research to the media, and beyond Aimed at researchers Thurs 11 June, 2pm  Book now 👇 https://www.medsci.ox.ac.uk/for-staff/opportunities-and-updates/media-training-for-researchers-and-communications-staff

Abstract submissions are now open for @cancerresearchuk.org & OHSU Knight Cancer Institute's Early Detection of Cancer Conference! 🔎 Submission deadline: 28 June 2026 📆 Find out more via the event website ⬇️ www.earlydetectionresearch.com

#WIMMReads 🧪 In a new perspective article, #MRCWIMM Professor Bethan Psaila explores how mutant calreticulin drives essential thrombocythemia and why it may represent a new therapeutic target. #Haematology #BloodCancer @rdm.ox.ac.uk @medsci.ox.ac.uk #AcademicSky

Register now for the Oxford Cancer Immuno-Oncology Network (OCION) Annual Symposium! When: Friday 19 June 🧪 Where: Mathematics Institute, Oxford 🔬 Tickets are going fast! ⬇️ @oncology.ox.ac.uk @medsci.ox.ac.uk @mplsoxford.bsky.social @oxcio.bsky.social www.eventbrite.co.uk/e/oxford-can...

There's still a few spaces left to attend our second annual Oxford Liver Cancer Centre of Excellence Symposium! Register before EOD today to secure your place! Details below 👇 @oncology.ox.ac.uk @medsci.ox.ac.uk @mplsoxford.bsky.social

🎉The world's largest study of women's health reaches 30 years! In May 1996, the first patient was recruited to the Million Women Study, a landmark study into the links between hormone replacement therapy (HRT) and breast cancer risk. 🔎 Learn more ➡️ buff.ly/nIeEiuA

Congratulations to Dr Natalie Jooss from the @bethpsaila.bsky.social lab, who is the latest winner in @cancerresearchuk.org's Research is Beautiful competition! 👏 Her winning image shows megakaryocytes (platelet-producing bone marrow cells) 👇 news.cancerresearchuk.org/2026/04/27/l...

In an advance for early cancer detection, a new Oxford-led study has received £3.6 million from the National Institute of Health and Care Research to evaluate breakthrough multi-cancer tests in NHS general practices! Read the full story on our website ⬇️

The DPhil in Cancer Science is inviting PIs from across Oxford University’s medical, physical, engineering, data, and mathematical sciences to submit their project ideas for its 2027 intake! Deadline: 12th June More information on our website ➡️ www.cancer.ox.ac.uk/study @medsci.ox.ac.uk

Our second annual Oxford Liver Cancer Centre of Excellence Symposium will focus on advancing scientific collaboration and ultimately improving outcomes for liver cancer! 🥼When: 14th May 🧪Where: Richard Doll Building @medsci.ox.ac.uk @oncology.ox.ac.uk www.eventbrite.co.uk/e/oxford-liv...

How can tumour-informed ctDNA analysis help refine recurrence risk assessment? 🤔 Find out in this free webinar with Dr. Tenna Vesterman Henriksen! In partnership with Bio-Rad on 30 April at 15:00-16:00 CEST 👉 Sign up here: eacr.org/meeting/eacr-bio-rad-webinar-apr26

Making research heard: communicating with policy professionals, Thu 7 May @oxpolicyengaged.bsky.social workshop designed for Medical Sciences researchers, research support & comms professionals. Places limited, book early ➡️ https://events.ox.ac.uk/oxford_event/9c7fadb0-9537-f111-88b5-7c1e52046959